Yuhan Corporation
Clinical trials sponsored by Yuhan Corporation, explained in plain language.
A South Korean pharmaceutical company developing drugs and vaccines.
Not investment advice. Company information is shown for context only. Clinical trials frequently fail.
-
New Triple-Drug combo aims to lower blood pressure better in seniors
Disease control OngoingThis study tests a new fixed-dose combination pill containing three blood pressure medicines (telmisartan, amlodipine, and chlorthalidone) against another triple combination (with hydrochlorothiazide instead of chlorthalidone) in elderly patients whose blood pressure is not well …
Phase: PHASE4 • Sponsor: Yuhan Corporation • Aim: Disease control
Last updated Jun 27, 2026 09:04 UTC
-
Healthy men needed to test experimental Drug's safety
Knowledge-focused OngoingThis early-stage study tests the safety and how the body handles a new oral drug, YH35995, in 86 healthy adult men. Participants receive either the drug or a placebo, and researchers monitor side effects and drug levels in the blood. The goal is to gather safety information, not …
Phase: PHASE1 • Sponsor: Yuhan Corporation • Aim: Knowledge-focused
Last updated Jul 30, 2026 00:00 UTC